Ann: Quarterly Update and Appendix 4C - quarterly, page-34

I know I sound like a broken record but case in point:

Last Thursday we had the good news of first patients dosed in the U.S. Shares rallied to about $1.40. Approx. 162k shares sold short on the day according to Shortman.
The share price was then managed/manipulated to close around $1. 21, down about 2 cents on what was a good news day. That's a 19 cent swing with 715k shares traded. It was blatant manipulation as you could see small trades dropping in every 1-2 minutes downticking the price.

On Friday we had a solid quarterly report and only about 270k shares traded. This looked like more normal trade as there was often 10 or 15 minutes between trades. There was a 6 cent swing in the price during the day. I doubt any shares were borrowed (will find out later today) and no sign of an algo working.

With the background of a biotech rout, the shorters have been able to manage our share price at will. Until the news and ongoing demand can overwhelm them, I believe this will continue. However with 008 and commercial deals in the next 6-12 months, we are definitely getting closer to an inflection point.